Press Releases

For more information Contact Priyanka Singh email:psingh@bestpracticesllc.com

Search Press Releases By Keyword

Filter By Year Filter By Month

2025

Best Practices, LLC Study Addresses the Challenge of Copay Accumulator Programs: Effective Pharma Strategies for Ensuring Patient Access

Across the healthcare landscape, rising out-of-pocket costs are putting essential specialty treatments out of reach for many patients. The growing prevalence of copay accumulator programs has made patient affordability a critical issue for manufacturers and patients alike.

Best Practices, LLC Showcases Benchmarking Study on “Medical’s Road Map for Social Media Success”

Social media has evolved into a critical channel for Medical Affairs to drive disease education, amplify thought leadership, and build trusted stakeholder relationships—while maintaining rigorous compliance.

Best Practices, LLC Releases Study on Digital Trends Driving Biopharma Launch Success

Recent biopharma landscape has accelerated the adoption of digital technologies, pushing companies to integrate complete digital strategies into their traditional launch models. Best Practices, LLC has released a groundbreaking benchmarking study, "Digital Trends in Biopharma Launch Strategy and Investment," highlighting how digital transformation is redefining launch excellence across the biopharma industry.

HCP Contracting Efficiency Emerges as a Strategic Driver of HCP Engagement: Best Practices Report Highlights Benchmarks and Tactics to Reduce Delays

Effective HCP contracting is critical for biopharma and medical device companies seeking impactful, compliant engagements with physicians and other healthcare professionals. Delays caused by fragmented workflows, manual approvals, and inconsistent documentation often slow down HCP collaborations, reducing the effectiveness of engagement programs.

Top Medical Affairs Leaders Reveal How AI Can Deliver Real Strategic Impact

Artificial intelligence is rapidly reshaping Medical Affairs, yet many organizations are still struggling to convert AI adoption into measurable results. To help companies navigate this evolving landscape, Best Practices, LLC has released its benchmarking report, "Current and Anticipated Applications of Artificial Intelligence (AI) in Medical Affairs."

Medical Sponsorships Emerge as Strategic Drivers of Education: Best Practices Report Explores Pharma’s Use of Social Media, Patient Groups & Virtual Formats

In today’s rapidly evolving healthcare landscape, medical education delivery has transformed. Pharma companies have shifted from traditional live meetings to multichannel strategies, with virtual formats, social media platforms, and patient group collaborations now central to engaging healthcare professionals and patients alike.

Medical Affairs Booth Effectiveness Under the Spotlight: New Report Highlights Strategies to Maximize Impact at Scientific Congresses

Medical Affairs teams are at the forefront of engaging healthcare professionals (HCPs) at critical scientific congresses, yet many struggle with maximizing the value of their booth presence.

Regulatory & Quality Spend Gap Shrinks 25%: New Report Reveals How MedTech Leaders Are Rebalancing Compliance Investments

In today’s rapidly advancing MedTech environment, Regulatory and Quality (RAQA) functions are no longer just about meeting compliance—they are emerging as strategic enablers of efficiency, innovation, and competitive advantage.

Medical Affairs 2030: New Report Reveals How Biopharma Companies Are Future-Proofing with AI, Innovation, and Strategic Resourcing

In an increasingly digital and patient-focused healthcare landscape, Medical Affairs is rapidly becoming the epicenter of cross-functional leadership, AI-driven insight generation, and scientific engagement.

Top Pharma Leaders Share New Insights on Strengthening Patient Advocacy Collaboration Across Functions

With growing emphasis on patient-centricity, biopharma leaders are investing more in advocacy partnerships—but many are still struggling with internal alignment, unclear decision rights, and approval bottlenecks.

Smarter IIT Investments: New Best Practices, LLC Report Reveals Key Strategies for Medical Affairs and IIT Leaders

As biopharmaceutical companies continue to drive meaningful advancements in clinical practice, optimizing Investigator-Initiated Trials (IITs) remains a top priority for Medical Affairs and IIT leaders.

Smarter Impact Metrics Help Medical Affairs Prove Value & Secure Resources

As Medical Affairs teams face growing expectations to deliver strategic value, many are moving away from activity-based metrics and embracing new ways to measure their impact.

AI & Advanced Analytics Are Transforming Competitive Intelligence in Biopharma

As the need for rapid market response grows, Competitive Intelligence (CI) functions in the biopharma industry are embracing the power of AI and advanced analytics to drive strategic decisions and stay ahead of competitors.

How Medical Affairs Can Become the Cornerstone of Immunology Product Launches

As immunology product launches become increasingly complex and competitive, Medical Affairs teams are taking center stage—driving strategy, scientific education, and digital engagement.

How Medical & Commercial Leaders Are Adapting to a Digitally-Enabled Future

With digital disruption reshaping every corner of the healthcare landscape, biopharmaceutical companies are racing to modernize how they engage with HCPs, patients, and internal teams.

How Leading Pharma Teams Are Reinventing Patient Support

As biopharma companies face growing pressure to demonstrate real-world impact, Best Practices, LLC’s benchmarking report uncovers how industry leaders are redefining patient support to deliver more than just financial assistance.

Driving Medical Affairs Launch Success through Strategic Resourcing

As the pressure to deliver successful product launches intensifies, Medical Affairs teams are stepping into a central strategic role.

Best Practices, LLC Report Reveals Pharma Launch Resourcing Benchmarks for Competitive Market Success

Biopharmaceutical companies continue to face unprecedented challenges when launching new therapies—tight market windows, evolving digital strategies, and shifting stakeholder expectations.

Best Practices, LLC Study Reveals Top Strategies to Optimize Medical Affairs and Market Access Teams in Medical Devices

As the medical device landscape becomes more complex and customer expectations evolve, successful companies are redesigning their Medical Affairs and Market Access functions for greater agility and impact.

Best Practices, LLC Report Uncovers Proven Strategies for Maximizing Mature Brands in Biopharma

In today’s crowded marketplace, maximizing the value of mature brands is more critical than ever for biopharma companies seeking sustained commercial success.

Best Practices, LLC Report Unlocks Strategies to Boost Medical Affairs Booth Effectiveness at Scientific Congresses

Biopharmaceutical companies continue to invest heavily in medical booth exhibits at scientific congresses, yet many struggle to maximize their return on these high-visibility initiatives.

Best Practices, LLC Report Reveals Proven Strategies for Successful Primary Care Launches in Biopharma

Targeting the right physicians at the right time is one of the most decisive factors in ensuring a biopharma product’s successful launch in primary care.

Best Practices, LLC Report Uncovers How Biopharma Medical and Commercial Teams Are Collaborating to Drive Greater Impact

In an era of rapid digital transformation and evolving customer demands, the partnership between Medical Affairs and Commercial functions has never been more critical.

Best Practices, LLC Report Uncovers How Pharma Leaders are Using Omnichannel to Maximize Digital Marketing Assets

As digital transformation accelerates across healthcare, pharmaceutical companies are revamping their marketing models to align with modern engagement needs.

Best Practices, LLC Report Reveals Strategies for Building a World-Class Medical Affairs Onboarding and Training Program

As Medical Affairs continues to expand its strategic influence, biopharma companies must ensure their Medical HQ teams are equipped with the right training and competencies from day one. A structured onboarding and training program is crucial to preparing new Medical leaders for success.

Best Practices for Building More Effective Medical Affairs Product Launch Teams

Medical Affairs is increasingly shaping the success of biopharma product launches, requiring strategic planning, cross-functional collaboration, and resource optimization. Yet, only 35% of organizations have a launch dashboard to track tactical, quality, and impact metrics.

Connected Health Excellence: Best Practices, LLC Report Reveals Key Insights on Integrated Treatment Apps

In the rapidly advancing healthcare space, leveraging connected healthcare applications is becoming essential for biopharma and medical device organizations to enhance device functionality and collect valuable treatment data.

Best Practices for Building High-Impact Patient Advocacy Partnerships in Pharma

In today’s evolving healthcare landscape, patient advocacy partnerships have become a crucial pillar for pharma companies aiming to enhance patient engagement and education. Organizations are refining their advocacy models to align with regulatory expectations, digital outreach, and long-term collaboration goals.

Case Study: Inside the First Fully Digital Pharma Launch – How Biohaven Launched Nurtec Successfully During the Pandemic

Launching a new drug is always a challenge, but doing so amid a global pandemic without traditional sales reps and in-person physician detailing required a groundbreaking approach. Biohaven rose to the occasion, delivering the first fully digital pharma launch with Nurtec.

Pharma's Digital Transformation: Best Practices, LLC Report Unveils Top Strategies for Patient Engagement

As the pharmaceutical landscape evolves, digital tools are reshaping how companies connect with patients, drive awareness, and optimize engagement strategies.

Scaling Pharma Teams for Launch Success: Best Practices, LLC Report Highlights Staffing Benchmarks

A successful product launch requires more than just a well-allocated budget; it depends on having the right team in place. To keep pace and achieve success, launch leaders must prioritize staffing for key activities.

Optimizing Pharma Launch Budgets: Best Practices, LLC Report Reveals Key Insights

Inefficient budget allocation is a key driver of product launch failures in the highly competitive pharmaceutical industry. To keep pace and ensure a successful launch, launch leaders need to devise strategic budget planning strategies.

Strategic Drug Positioning: Best Practices, LLC Report Reveals Key Strategies for Product Launches

In the fast-paced world of biopharmaceuticals, executing the new product planning framework is crucial to avoid costly missteps and ensure long-term market success.

Training & Developing High-Impact Medical Affairs Professionals | Best Practices

With the growing importance of the Medical Affairs function in biopharma, organizations face increasing pressure to enhance their training and development programs to develop high-performing professionals.